期刊文献+

PI3K/AKT信号通路在常见神经退行性疾病中的机制研究进展 被引量:14

Roles of PI3K/AKT Signaling Pathway in Neurodegenerative Diseases
在线阅读 下载PDF
导出
摘要 神经退行性疾病是一类以大脑和脊髓中特定的神经元损伤或丢失为主要病理特征的疾病。常见的神经退行性疾病包括阿尔兹海默症(AD)、帕金森症(PD)、肌萎缩侧索硬化(ALS)、亨廷顿病(HD)和多发性硬化(MS),给患者及其家庭带来了很大的困扰,也造成了很大的社会经济负担,已成为全球性的健康问题。近年来,PI3K/AKT信号路径作为一种参与多种细胞功能的信号通路,在多种神经退行性疾病中的作用被广泛研究。本文总结了PI3K/AKT信号通路在常见神经退行性疾病中的作用机制,并对其在不同神经退行性疾病及癌症中的作用异同进行了讨论,进而展望未来相应领域的理论研究及在药物开发中的应用趋势。 Neurodegenerative diseases are a type of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral nervous system.Common neurodegenerative diseases include Alzheimer's disease(AD),Parkinson's disease(PD),amyotrophic lateral sclerosis(ALS),Huntington's disease(HD)and multiple sclerosis(MS).These diseases have brought great troubles to patients and their families,also caused a great social and economic burden,and become a global health problem.In recent years,it has been reported that PI3K/AKT signaling pathway is involved in a variety of cellular functions in neurodegenerative diseases.This review summarized the roles of PI3K/AKT signaling pathway in common neurodegenerative diseases and discussed its similarities and differences between neurodegenerative diseases and cancers,and then presents the future prospects of PI3K/AKT signaling pathway in mechanism study and drug development for neurodegenerative diseases.
作者 傅文垚 罗建平 刘长虹 FU Wen-Yao;LUO Jian-Ping;LIU Chang-Hong(School of Food Science and Engineering, Hefei University of Technology, Hefei 230009, China)
出处 《生物技术通讯》 CAS 2017年第6期853-859,共7页 Letters in Biotechnology
关键词 神经退行性疾病 PI3K/AKT信号通路 阿尔兹海默症 帕金森症 肌萎缩侧索硬化 亨廷顿病 多发性硬化 neurodegenerative diseases PI3K/AKT signaling pathway Alzheimer's disease Parkinson's disease amyotrophic lateral sclerosis Huntington's disease multiple sclerosis
  • 相关文献

参考文献2

二级参考文献47

  • 1Dongxiao Liu,Qingmin Sun,Song Liang,Linlin Xu,Xuan Luo,Xiaomei Zhao,Xuerong Wang,Li Yang.MicroRNA-27a inhibitors alone or in combination with perifosine suppressthe growth of gastric cancer cells[J].Molecular Medicine Reports.2013(2)
  • 2Song Liang,Renhua Guo,Zhihong Zhang,Dongxiao Liu,Hao Xu,Zekuan Xu,Xuerong Wang,Li Yang.Upregulation of the eIF4E signaling pathway contributes to the progressionof gastric cancer, and targeting eIF4E by perifosine inhibits cell growth[J]. Oncology Reports . 2013 (6)
  • 3Dos D. Sarbassov,David A. Guertin,Siraj M. Ali,David M. Sabati.Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex. Science . 2005
  • 4Chun-Zhi Zhang,Lei Han,An-Ling Zhang,Yan-Chao Fu,Xiao Yue,Guang-Xiu Wang,Zhi-Fan Jia,Pei-Yu Pu,Qing-Yu Zhang,Chun-Sheng Kang.MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer . 2010
  • 5Sun‐ju Byeon,Nayoung Han,Jiwoon Choi,Min A Kim,Woo Ho Kim.Prognostic implication of TSC1 and mTOR expression in gastric carcinoma[J]. J. Surg. Oncol. . 2014 (8)
  • 6Jing He,Meng‐Yun Wang,Li‐Xin Qiu,Mei‐Ling Zhu,Ting‐Yan Shi,Xiao‐Yan Zhou,Meng‐Hong Sun,Ya‐Jun Yang,Jiu‐Cun Wang,Li Jin,Ya‐Nong Wang,Jin Li,Hong‐Ping Yu,Qing‐Yi Wei.Genetic variations of mTORC1 genes and risk of gastric cancer in an eastern chinese population[J]. Mol. Carcinog. . 2013 (S1)
  • 7Wenbin Huang,Li Yang,Song Liang,Dongxiao Liu,Xi Chen,Zhuo Ma,Sulan Zhai,Ping Li,Xuerong Wang.AEG-1 Is a Target of Perifosine and Is Over-Expressed in Gastric Dysplasia and Cancers[J]. Digestive Diseases and Sciences . 2013 (10)
  • 8Joan T. Garrett,Cammie R. Sutton,Richard Kurupi,Carl Uli Bialucha,Seth A. Ettenberg,Scott D. Collins,Qing Sheng,Jerry Wallweber,Lisa DeFazio-Eli,Carlos L. Arteaga.Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers[J]. Cancer Research . 2013 (19)
  • 9Ningshu Liu,Bruce R. Rowley,Cathy O. Bull,Claudia Schneider,Andrea Haegebarth,Christoph A. Schatz,Paul R. Fracasso,Dean P. Wilkie,Martin Hentemann,Scott M. Wilhelm,William J. Scott,Dominik Mumberg,Karl Ziegelbauer.BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models[J]. Molecular Cancer Therapeutics . 2013 (11)
  • 10Chang-Ηua Zhang,Niranjan Awasthi,Margaret Schwarz,Roderich Schwarz.The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumorresponse in experimental gastric cancer[J]. International Journal of Oncology . 2013 (5)

共引文献35

同被引文献197

引证文献14

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部